Recent developments in AI are advancing the next novel therapies and diagnostics. Proscia is proud to power the world’s life sciences leaders to accelerate drug R&D, build novel diagnostics, and reach more patients.
Why Proscia?
- Our software platform, real-world data, and AI power precision medicine from discovery to diagnostics
- Our user base includes 14 of the top 20 pharma leaders and major diagnostic laboratories
- Access to 6M+ patients per year around the world
Let's discuss pathology’s elevated role in the precision medicine paradigm.
About Proscia
Proscia is a software company accelerating pathology’s transition to a digital, data-driven discipline and enabling AI to advance precision medicine. Its Concentriq® enterprise pathology platform, precision medicine AI portfolio, and real-world data fuel the development and use of novel therapies and diagnostics to drive the fight against humanity’s most challenging diseases, like cancer.